NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)

Historical Holders from Q2 2021 to Q3 2025

Symbol
NPCE on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
33,235,472
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
25,945,404
Holdings value
$267,500,978
% of all portfolios
0%
Number of holders
80
Number of buys
42
Number of sells
-49
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Polar Capital Holdings Plc 9.13% $34,534,675 2,972,003 Polar Capital Holdings Plc 31 Mar 2025
Soleus Private Equity Fund I, L.P. 8.9% $30,496,537 2,957,957 Guy Levy 30 Sep 2025
ORBIMED ADVISORS LLC 8% -23% $26,716,960 -$8,095,783 2,614,184 -23% OrbiMed Advisors LLC 30 Jun 2025
MORGAN STANLEY 8.3% $28,926,723 2,489,391 Morgan Stanley 31 Dec 2024
Soleus Capital Master Fund, L.P. 7% $23,545,122 2,303,828 Soleus Capital Management, L.P. 30 Jun 2025
Kent Lake PR LLC 4.9% -2% $17,227,289 +$116,944 1,482,555 +0.68% Kent Lake PR LLC 31 Dec 2024

Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 25,945,404 $267,500,978 +$34,175,646 $10.31 80
2025 Q2 22,505,448 $250,711,399 -$19,749,912 $11.14 98
2025 Q1 23,932,784 $294,127,661 +$42,108,506 $12.29 89
2024 Q4 20,868,828 $233,522,000 +$8,990,314 $11.19 61
2024 Q3 14,795,861 $103,125,040 +$1,471,249 $6.97 48
2024 Q2 14,430,601 $109,095,635 +$4,457,712 $7.56 51
2024 Q1 13,364,973 $176,414,273 +$9,053,052 $13.2 53
2023 Q4 12,690,314 $130,836,764 +$2,444,618 $10.31 41
2023 Q3 18,073,997 $175,859,892 +$5,454,271 $9.73 24
2023 Q2 17,503,080 $78,589,150 -$756,243 $4.49 20
2023 Q1 17,670,188 $81,990,736 +$1,754,483 $4.64 24
2022 Q4 17,357,024 $25,862,002 -$2,680,436 $1.49 22
2022 Q3 18,161,017 $68,102,000 -$1,024,177 $3.75 27
2022 Q2 18,426,044 $91,207,000 -$26,340 $4.95 26
2022 Q1 18,210,639 $149,512,180 -$117,404 $8.21 37
2021 Q4 18,012,051 $181,543,000 +$1,949,052 $10.08 41
2021 Q3 11,190,051 $177,393,000 +$509,015 $15.85 39
2021 Q2 10,905,701 $259,451,000 +$259,451,000 $23.79 44